サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1510755

北米のマラリア治療薬市場：2030年予測と地域別分析：治療薬別、投与経路別、流通チャネル別

North America Malaria Treatment Market Forecast to 2030 - Regional Analysis - by Treatment, Route of Administration, and Distribution Channel

出版日
ページ情報
英文 84 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
北米のマラリア治療薬市場：2030年予測と地域別分析：治療薬別、投与経路別、流通チャネル別
出版日: 2024年05月07日
発行: The Insight Partners
ページ情報: 英文 84 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米のマラリア治療薬市場は、2022年に6,297万米ドルと評価され、2030年には4億8,731万米ドルに達すると予測され、2022年から2030年までのCAGRは29.1%で成長すると予測されています。

マラリア有病率の増加が北米のマラリア治療薬市場を後押し

マラリアは急性熱性疾患のひとつで、原虫によって引き起こされ、感染した雌のアノフェレス蚊を介して広がります。ヒトに寄生する5種の寄生虫が主にマラリアを引き起こし、そのうちの2種、マラリア原虫とマラリア原虫vivaxがヒトの健康に対する最大の脅威と考えられています。また、P.falciparumは最も致死率の高いマラリア原虫であり、アフリカ大陸に最も広く蔓延しています。さらに、P.vivaxはサハラ以南のアフリカ以外のほとんどの国で支配的なマラリア寄生虫です。世界保健機関（WHO）が発表した最新の世界マラリア報告（WMR）2020によると、世界で報告されたマラリアの症例数は2億4,100万件で、2019年には2億2,700万件でした。同報告書によると、マラリアによる死亡者数は年間6万9000人増加しています。このうち約3分の2の4万7,000人は、COVID-19の流行による調査手法の混乱が原因であり、残りの3分の1の2万2,000人は、WHOのマラリア死亡率算出手法の最近の変更を反映したものである（COVID-19の混乱とは無関係）。このように、マラリアの有病率の上昇がマラリア治療市場の成長を後押ししています。

北米のマラリア治療薬市場概要

米国疾病予防管理センター（CDC）によると、米国では年間約2,000件のマラリア症例が報告されており、そのほとんどが他国からの旅行者や移民です。妊婦と5歳未満の子供がマラリアに感染し、重症化するリスクが最も高いです。米国にはマラリアを媒介するアノフェレス蚊（媒介蚊）が生息しているため、米国でマラリア感染が再開するリスクは常に存在します。2022年4月の世界基金のデータによると、マラリアに関する患者数と死亡数は、主に資金調達の停滞とCOVID-19パンデミックによる混乱によって増加しました。しかし、2022年9月の世界基金の報告書で言及されたように、こうした影響を緩和するための取り組みには進展が見られました。米国政府によるマラリア制圧への取り組みには、主に米国世界マラリア調整官が監督する米国大統領マラリア・イニシアティブ（PMI）を通じた活動が含まれます。世界・ヘルス・ポリシーによると、米国のマラリア対策・研究活動に対する資金は、2022年度で約10億米ドルでした。PMI戦略2021-2026における米国政府の目標は、マラリアによる死亡を減少させ、マラリアの罹患率を減少させることであり、ひいてはマラリア撲滅という長期目標に近づくことです。

このように、米国のマラリア治療市場の成長は、マラリア患者数の増加によってもたらされます。

北米のマラリア治療薬市場の収益と2030年までの予測

北米のマラリア治療薬市場のセグメンテーション

北米のマラリア治療薬市場は、治療法、投与経路、流通チャネル、国に基づいて細分化されます。治療法に基づき、北米のマラリア治療薬市場はジェネリック医薬品、先発医薬品、ワクチン、その他に区分されます。2022年にはワクチン分野が最大の市場シェアを占めています。

投与経路では、北米のマラリア治療薬市場は経口薬と非経口薬に二分されます。2022年の市場シェアは経口剤セグメントが大きいです。

流通チャネル別では、北米のマラリア治療薬市場は直接入札、病院薬局、小売薬局、オンライン薬局、その他に区分されます。直接入札セグメントが2022年に最大の市場シェアを占めました。

国別では、北米のマラリア治療薬市場は米国、カナダ、メキシコに区分されます。2022年の北米のマラリア治療薬市場シェアは米国が独占しました。

Cipla Ltd、Sun Pharmaceutical Industries Ltd、Sanofi SA、GSK Plc、Novartis AG、Pfizer Inc、AdvaCare Pharma USA LLC、VLP Therapeutics LLC、Lupin Ltdなどが北米のマラリア治療薬市場で事業を展開する大手企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要洞察-マラリア

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 北米のマラリア治療薬市場- 主要産業力学

  • 主な市場促進要因
    • マラリアの有病率の増加
    • マラリアに関する意識向上への取り組みの高まり
  • 市場抑制要因
    • 偽造抗マラリア薬の入手可能性とその後の薬剤耐性
  • 市場機会
    • 市場企業による戦略的イニシアチブの高まり
  • 今後の動向
    • 新薬とワクチンのパイプラインの拡大
  • 影響分析

第5章 マラリア治療市場：北米市場分析

  • 北米のマラリア治療薬市場売上高、2022年～2030年

第6章 北米のマラリア治療薬市場：2030年までの収益と予測：治療薬別

  • ワクチン
  • ジェネリック医薬品
  • 先発医薬品
  • その他

第7章 北米のマラリア治療薬市場：2030年までの収益と予測：投与経路別

  • 経口剤
  • 非経口

第8章 北米のマラリア治療薬市場：2030年までの収益と予測：流通チャネル別

  • 直接入札
  • 病院薬局
  • 小売薬局
  • オンライン薬局
  • その他

第9章 北米のマラリア治療薬市場：国別分析

  • 北米
  • 米国
  • カナダ
  • メキシコ

第10章 マラリア治療市場の業界情勢

  • マラリア治療市場における成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第11章 企業プロファイル

  • Cipla Ltd
  • Sun Pharmaceutical Industries Ltd
  • Sanofi SA
  • GSK Plc
  • Novartis AG
  • Pfizer Inc
  • AdvaCare Pharma USA LLC
  • VLP Therapeutics LLC
  • Lupin Ltd

第12章 付録

図表

List Of Tables

  • Table 1. Malaria Treatment Market Segmentation
  • Table 2. Malaria Drugs/Vaccine/Compounds Under Clinical Development
  • Table 3. Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 4. Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Retail Pharmacies
  • Table 5. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 6. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 7. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 8. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 9. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 10. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 11. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 12. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 13. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 14. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 15. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 16. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 17. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 18. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 19. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 20. Recent Inorganic Growth Strategies in the Malaria Treatment Market
  • Table 21. Recent Organic Growth Strategies in the Malaria Treatment Market
  • Table 22. Glossary of Terms, Malaria Treatment Market

List Of Figures

  • Figure 1. Malaria Treatment Market - Key Industry Dynamics
  • Figure 2. Impact Analysis of Drivers and Restraints
  • Figure 3. North America Malaria Treatment Market Revenue (US$ million), 2022 - 2030
  • Figure 4. North America Malaria Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
  • Figure 5. Vaccines Market Revenue and Forecasts to 2030 (US$ Mn)
  • Figure 6. Generic Drugs Market Revenue and Forecasts to 2030 (US$ Mn)
  • Figure 7. Originators Market Revenue and Forecasts to 2030 (US$ Mn)
  • Figure 8. Others Market Revenue and Forecasts to 2030 (US$ Mn)
  • Figure 9. North America Malaria Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
  • Figure 10. Oral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Parenteral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. North America Malaria Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • Figure 13. Direct Tender: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Hospital Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Retail Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Online Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Others: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. North America Malaria Treatment Market, By Country, 2022 ($Mn)
  • Figure 19. North America: Malaria Treatment Market, By Key Countries, 2022 and 2030 (%)
  • Figure 20. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 21. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 22. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 23. Growth Strategies in the Malaria Treatment Market
目次
Product Code: TIPRE00025040

The North America malaria treatment market was valued at US$ 62.97 million in 2022 and is expected to reach US$ 487.31 million by 2030; it is estimated to grow at a CAGR of 29.1% from 2022 to 2030.

Increasing Prevalence of Malaria Fuels North America Malaria Treatment Market

Malaria, one of the acute febrile illnesses, is caused by plasmodium parasites and spreads through the infected female Anopheles mosquitoes. Five parasite species in humans mainly cause malaria, and two of these species-Plasmodium falciparum and P. vivax-are considered the greatest threat to human health. Also, P. falciparum is the deadliest malarial parasite, and it is most widely spread across the African continent. Further, P. vivax is the dominant malarial parasite in most countries outside of sub-Saharan Africa. According to the latest World Malaria Report (WMR) 2020 from the World Health Organization (WHO), 241 million cases of malaria were reported in the world, in comparison to 227 million cases that were logged in 2019. According to the same source, the number of deaths caused due to malaria has an annual rise of 69,000 deaths. Approximately two-thirds of these deaths, i.e., 47,000, were caused by disruptions in healthcare services during the COVID-19 outbreak; the remaining one-third of deaths, i.e., 22,000 reflected a recent change in the WHO's methodology for calculating malaria mortality (irrespective of COVID-19 disruptions). Thus, the rising prevalence of malaria boosts the malaria treatment market growth.

North America Malaria Treatment Market Overview

According to the Centers for Disease Control and Prevention (CDC), approximately 2,000 cases of malaria are reported annually in the US, mostly in travelers from other countries and immigrants. Pregnant women and children under 5 years of age are at the highest risk of contracting malaria and developing severe diseases. There is a perpetual risk that malaria transmission can resume in the US due to the endurance of anopheles mosquitoes (vectors) capable of transmitting malaria in the US. According to the Global Fund data from April 2022, cases and deaths related to malaria rose mainly due to stalled funding and disruptions caused by the COVID-19 pandemic. However, efforts to moderate these impacts have seen progress, as mentioned in the Global Fund report in September 2022. Efforts taken by the US government to control malaria include activities primarily through the US President's Malaria Initiative (PMI), overseen by the US Global Malaria Coordinator. According to Global Health Policy, US funding for malaria control and research activities was approximately US$ 1 billion in FY 2022. The US government's goal under the PMI Strategy 2021-2026 is to work and reduce deaths caused by malaria and decrease malaria morbidity, in turn approaching its long-term goal of elimination.

Thus, the malaria treatment market growth in the US is driven by the rising number of malaria patients.

North America Malaria Treatment Market Revenue and Forecast to 2030 (US$ Million)

North America Malaria Treatment Market Segmentation

The North America malaria treatment market is segmented based on treatment, route of administration, distribution channel, and country. Based on treatment, the North America malaria treatment market is segmented into generic drugs, originators, vaccines, and others. The vaccines segment held the largest market share in 2022.

In terms of route of administration, the North America malaria treatment market is bifurcated into oral and parenteral. The oral segment held a larger market share in 2022.

By distribution channel, the North America malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. The direct tender segment held the largest market share in 2022.

Based on country, the North America malaria treatment market is segmented into the US, Canada, and Mexico. The US dominated the North America malaria treatment market share in 2022.

Cipla Ltd, Sun Pharmaceutical Industries Ltd, Sanofi SA, GSK Plc, Novartis AG, Pfizer Inc, AdvaCare Pharma USA LLC, VLP Therapeutics LLC, and Lupin Ltd are some of the leading players operating in the North America malaria treatment market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights - Malaria

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Malaria Treatment Market - Key Industry Dynamics

  • 4.1 Key Market Drivers:
    • 4.1.1 Increasing Prevalence of Malaria
    • 4.1.2 Rising Initiatives to Raise Awareness about Malaria
  • 4.2 Market Restraints
    • 4.2.1 Availability of Counterfeit Antimalarial Drugs Followed by Subsequent Drug Resistance
  • 4.3 Market Opportunities
    • 4.3.1 Growing Strategic Initiatives by Market Players
  • 4.4 Future Trends
    • 4.4.1 Extending Pipeline of New Drugs and Vaccines
  • 4.5 Impact Analysis

5. Malaria Treatment Market - North America Market Analysis

  • 5.1 North America Malaria Treatment Market Revenue (US$ million), 2022 - 2030

6. North America Malaria Treatment Market - Revenue and Forecast to 2030 - by Treatment

  • 6.1 Overview
  • 6.2 North America Malaria Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
  • 6.3 Vaccines
    • 6.3.1 Overview
    • 6.3.2 Vaccines Market Revenue and Forecast to 2030 (US$ Mn)
  • 6.4 Generic Drugs
    • 6.4.1 Overview
    • 6.4.2 Generic Drugs Market Revenue and Forecast to 2030 (US$ Mn)
  • 6.5 Originators
    • 6.5.1 Overview
    • 6.5.2 Originators Market Revenue and Forecast to 2030 (US$ Mn)
  • 6.6 Others
    • 6.6.1 Overview
    • 6.6.2 Others Market Revenue and Forecast to 2030 (US$ Mn)

7. North America Malaria Treatment Market - Revenue and Forecast to 2030 - by Route of Administration

  • 7.1 Overview
  • 7.2 North America Malaria Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
  • 7.3 Oral
    • 7.3.1 Overview
    • 7.3.2 Oral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Parenteral
    • 7.4.1 Overview
    • 7.4.2 Parenteral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Malaria Treatment Market - Revenue and Forecast to 2030 - by Distribution Channel

  • 8.1 Overview
  • 8.2 North America Malaria Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • 8.3 Direct Tender
    • 8.3.1 Overview
    • 8.3.2 Direct Tender: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Hospital Pharmacies
    • 8.4.1 Overview
    • 8.4.2 Hospital Pharmacies: Malaria Market - Revenue and Forecast to 2030 (US$ Million)
        • 8.4.2.1.1 Malaria Treatment Market, by Hospital Pharmacies
  • 8.5 Retail Pharmacies
    • 8.5.1 Overview
    • 8.5.2 Retail Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 8.5.2.1.1 Malaria Treatment Market, by Retail Pharmacies
  • 8.6 Online Pharmacies
    • 8.6.1 Overview
    • 8.6.2 Online Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Others
    • 8.7.1 Overview
    • 8.7.2 Others: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Malaria Treatment Market - Country Analysis

  • 9.1 North America Malaria Treatment Market, Revenue and Forecast To 2030
    • 9.1.1 Overview
      • 9.1.1.1 North America: Malaria Treatment Market, by Country
      • 9.1.1.2 US
      • 9.1.1.3 Overview
        • 9.1.1.3.1 US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.3.2 US: Malaria Treatment Market, by Treatment
        • 9.1.1.3.3 US: Malaria -Malaria Treatment Market, by Route of Administration
        • 9.1.1.3.4 US: Malaria Treatment Market, by Distribution Channel
        • 9.1.1.3.4.1 US: Malaria Treatment Market, by Hospital Pharmacies
        • 9.1.1.3.4.2 US: Malaria Treatment Market, by Retail Pharmacies
      • 9.1.1.4 Canada
      • 9.1.1.5 Overview
        • 9.1.1.5.1 Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.5.2 Canada: Malaria Treatment Market, by Treatment
        • 9.1.1.5.3 Canada: Malaria -Malaria Treatment Market, by Route of Administration
        • 9.1.1.5.4 Canada: Malaria Treatment Market, by Distribution Channel
        • 9.1.1.5.4.1 Canada: Malaria Treatment Market, by Hospital Pharmacies
        • 9.1.1.5.4.2 Canada: Malaria Treatment Market, by Retail Pharmacies
      • 9.1.1.6 Mexico
      • 9.1.1.7 Overview
        • 9.1.1.7.1 Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.7.2 Mexico: Malaria Treatment Market, by Treatment
        • 9.1.1.7.3 Mexico: Malaria -Malaria Treatment Market, by Route of Administration
        • 9.1.1.7.4 Mexico: Malaria Treatment Market, by Distribution Channel
        • 9.1.1.7.4.1 Mexico: Malaria Treatment Market, by Hospital Pharmacies
        • 9.1.1.7.4.2 Mexico: Malaria Treatment Market, by Retail Pharmacies

10. Malaria Treatment Market Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in the Malaria Treatment Market
  • 10.3 Inorganic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Organic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 Cipla Ltd
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Sun Pharmaceutical Industries Ltd
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Sanofi SA
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 GSK Plc
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Novartis AG
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Pfizer Inc
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Service
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 AdvaCare Pharma USA LLC
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 VLP Therapeutics LLC
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 Lupin Ltd
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments

12. Appendix

  • 12.1 About Us
  • 12.2 Glossary of Terms